LATTANZIO, ROSSANO
 Distribuzione geografica
Continente #
NA - Nord America 2.695
EU - Europa 2.492
AS - Asia 1.469
SA - Sud America 165
AF - Africa 11
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.846
Nazione #
US - Stati Uniti d'America 2.676
IT - Italia 729
SG - Singapore 667
IE - Irlanda 435
CN - Cina 404
SE - Svezia 288
UA - Ucraina 243
TR - Turchia 202
GB - Regno Unito 180
DE - Germania 179
FR - Francia 170
BR - Brasile 157
IN - India 83
FI - Finlandia 74
RU - Federazione Russa 54
AT - Austria 41
VN - Vietnam 37
HK - Hong Kong 30
CZ - Repubblica Ceca 24
BE - Belgio 20
NL - Olanda 19
JP - Giappone 13
CA - Canada 12
AU - Australia 10
PL - Polonia 7
LT - Lituania 4
MO - Macao, regione amministrativa speciale della Cina 4
MX - Messico 4
CH - Svizzera 3
EC - Ecuador 3
EE - Estonia 3
ES - Italia 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
RS - Serbia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BG - Bulgaria 2
BY - Bielorussia 2
CU - Cuba 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
IQ - Iraq 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
DZ - Algeria 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 6.846
Città #
Chandler 498
Singapore 476
Dublin 426
Jacksonville 327
Princeton 160
Ashburn 145
Santa Clara 131
Southend 124
Dearborn 112
Pescara 110
The Dalles 103
Izmir 102
Chieti 100
Nanjing 96
Ann Arbor 78
Beijing 78
Altamura 73
Wilmington 73
Boardman 51
Cambridge 50
Los Angeles 40
New York 40
Collecorvino 36
Dong Ket 34
Nanchang 31
Vienna 31
Hong Kong 28
Shenyang 27
Washington 26
Milan 25
Munich 25
Rome 25
Woodbridge 24
Hebei 21
Ancona 20
Brussels 18
Brno 17
Jiaxing 16
Tianjin 16
Helsinki 15
Nuremberg 15
San Vito Chietino 15
Frankfurt am Main 14
Houston 14
London 14
Lappeenranta 13
Grevenbroich 12
Jinan 12
Catania 11
Messina 11
Kunming 10
Seattle 10
São Paulo 9
Bologna 8
Chicago 8
Norwalk 8
Rio de Janeiro 8
Castignano 7
Changsha 7
Kraków 7
Medford 7
Ottawa 7
Pullman 7
Amsterdam 6
Ascoli Piceno 6
Carrara 6
Düsseldorf 6
Grafing 6
Guangzhou 6
Oklahoma City 6
Orange 6
Oxford 6
Romola 6
Shanghai 6
Edinburgh 5
Florence 5
Hangzhou 5
Niigata 5
Ningbo 5
Pune 5
Spoltore 5
Sydney 5
Zhengzhou 5
Campinas 4
Carini 4
Cattolica 4
Horley 4
Lanzhou 4
Loma Linda 4
Macao 4
Mcallen 4
Olomouc 4
Ponte San Pietro 4
Salvador 4
Taizhou 4
Toronto 4
Turku 4
Bari 3
Basciano 3
Brasília 3
Totale 4.238
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 186
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 183
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 153
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 137
Trop-2 is a determinant of breast cancer survival. 136
A unique four-hub protein cluster associates to glioblastoma progression 131
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 119
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 118
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 110
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 110
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 107
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 105
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 104
ABCC3 is a novel target for the treatment of pancreatic cancer 104
The Trop-2 signalling network in cancer growth 103
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 102
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 102
Molecular studies of pulmonary carcinoids 101
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 100
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 99
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 99
Prognostic relevance of LGALS3BP in human colorectal carcinoma 99
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 98
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 96
Exosomes as pleiotropic players in pancreatic cancer 96
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 95
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 95
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 93
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 93
Upregulation of Trop-2 quantitatively stimulates human cancer growth 92
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 92
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 92
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 91
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 91
Pioneers in Pathology 91
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 90
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 90
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 89
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 89
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 88
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 88
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 86
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 86
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 85
[Tissue microarrays] 85
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 84
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 82
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 81
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 79
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 79
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 78
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 77
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 77
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 76
The role of phospholipase Cγ1 in breast cancer and its clinical significance 76
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 75
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 72
Role of phospholipase C in cell invasion and metastasis 72
Phospholipase Cgamma1 is required for metastasis development and progression 71
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 66
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 66
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 65
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 64
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 64
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 63
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 59
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 56
null 56
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 55
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 54
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 53
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 52
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 52
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 49
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 48
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 48
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 45
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 41
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 41
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 39
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 37
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 37
Loss of primary cilia promotes inflammation and carcinogenesis 35
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 35
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 34
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 34
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 32
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 30
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 30
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 29
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 27
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 26
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 23
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 20
null 20
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 9
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 3
Totale 7.375
Categoria #
all - tutte 33.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020107 0 0 0 0 0 0 0 0 0 0 91 16
2020/2021512 69 8 77 27 63 83 18 10 43 48 11 55
2021/2022512 17 7 25 126 14 47 10 24 31 22 64 125
2022/20231.337 104 236 78 135 138 219 69 121 138 17 42 40
2023/2024908 52 28 67 38 52 288 175 42 25 31 12 98
2024/20251.949 89 439 375 88 76 114 161 146 241 144 76 0
Totale 7.375